James Investment Research Inc Astrazeneca PLC Transaction History

James Investment Research Inc

$819 Million
Q4 2024

A detailed history of James Investment Research Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, James Investment Research Inc holds 66,235 shares of AZN stock, worth $4.7 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares

66,235

Previous 83,088 20.28%

Holding current value

$4.7 Million

Previous $6.47 Million 32.98%

% of portfolio

0.53%

Previous 0.76%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 30, 2025	SELL	$63.2 - $79.58 $1.07 Million - $1.34 Million	-16,853 Reduced 20.28%	66,235 $4.34 Million
Q3 2024 Oct 29, 2024	SELL	$76.67 - $87.62 $40,481 - $46,263	-528 Reduced 0.63%	83,088 $6.47 Million
Q2 2024 Jul 30, 2024	SELL	$66.81 - $80.83 $749,741 - $907,074	-11,222 Reduced 11.83%	83,616 $6.52 Million
Q1 2024 May 01, 2024	SELL	$61.03 - $69.57 $561,109 - $639,626	-9,194 Reduced 8.84%	94,838 $6.43 Million
Q4 2023 Feb 06, 2024	SELL	$61.89 - $69.28 $55,082 - $61,659	-890 Reduced 0.85%	104,032 $7.01 Million
Q3 2023 Oct 31, 2023	SELL	$64.85 - $71.7 $23,086 - $25,525	-356 Reduced 0.34%	104,922 $7.11 Million
Q2 2023 Aug 07, 2023	SELL	$69.91 - $75.81 $47,468 - $51,474	-679 Reduced 0.64%	105,278 $7.53 Million
Q1 2023 Apr 25, 2023	BUY	$63.15 - $71.6 $155,475 - $176,279	2,462 Added 2.38%	105,957 $7.35 Million
Q4 2022 Jan 30, 2023	SELL	$54.21 - $70.44 $167,346 - $217,448	-3,087 Reduced 2.9%	103,495 $7.02 Million
Q3 2022 Oct 31, 2022	BUY	$53.02 - $135.75 $49,891 - $127,740	941 Added 0.89%	106,582 $5.85 Million
Q2 2022 Aug 01, 2022	SELL	$59.26 - $71.14 $56,889 - $68,294	-960 Reduced 0.9%	105,641 $6.98 Million
Q1 2022 Apr 22, 2022	SELL	$55.72 - $67.12 $1.06 Million - $1.28 Million	-19,004 Reduced 15.13%	106,601 $7.07 Million
Q4 2021 Jan 28, 2022	SELL	$54.02 - $63.83 $291,653 - $344,618	-5,399 Reduced 4.12%	125,605 $7.32 Million
Q3 2021 Oct 22, 2021	SELL	$55.56 - $60.79 $526,819 - $576,410	-9,482 Reduced 6.75%	131,004 $7.87 Million
Q2 2021 Jul 26, 2021	SELL	$48.42 - $60.18 $23,435 - $29,127	-484 Reduced 0.34%	140,486 $8.42 Million
Q1 2021 Apr 22, 2021	SELL	$47.16 - $54.44 $1.21 Million - $1.4 Million	-25,661 Reduced 15.4%	140,970 $7.01 Million
Q4 2020 Jan 27, 2021	SELL	$48.52 - $58.02 $614,214 - $734,475	-12,659 Reduced 7.06%	166,631 $8.33 Million
Q3 2020 Oct 23, 2020	BUY	$53.07 - $61.1 $4.65 Million - $5.36 Million	87,705 Added 95.76%	179,290 $9.83 Million
Q2 2020 Jul 24, 2020	BUY	$43.1 - $55.31 $3.95 Million - $5.06 Million	91,542 Added 212888.38%	91,585 $4.84 Million
Q1 2020 Apr 22, 2020	BUY	$37.79 - $51.33 $1,624 - $2,207	43 New	43 $1,000
Q2 2019 Jul 24, 2019	SELL	$37.28 - $41.68 $9,320 - $10,420	-250 Closed	0 $0
Q1 2019 Apr 26, 2019	BUY	$35.49 - $43.02 $8,872 - $10,755	250 New	250 $10,000

Others Institutions Holding AZN

# of Institutions

1,336

Shares Held

477M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $220B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of James Investment Research Inc, based on Form 13F filings with the SEC.

News

Stay updated on James Investment Research Inc with notifications on news.

Account

James Investment Research Inc Astrazeneca PLC Transaction History